Cargando…
Clinical Trial End Points in Severe COVID-19
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mayo Foundation for Medical Education and Research
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275157/ https://www.ncbi.nlm.nih.gov/pubmed/32753131 http://dx.doi.org/10.1016/j.mayocp.2020.05.025 |
| _version_ | 1783542727383711744 |
|---|---|
| author | Desai, Aakash Kulkarni, Amit Rajkumar, S. Vincent Gyawali, Bishal |
| author_facet | Desai, Aakash Kulkarni, Amit Rajkumar, S. Vincent Gyawali, Bishal |
| author_sort | Desai, Aakash |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7275157 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Mayo Foundation for Medical Education and Research |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72751572020-06-08 Clinical Trial End Points in Severe COVID-19 Desai, Aakash Kulkarni, Amit Rajkumar, S. Vincent Gyawali, Bishal Mayo Clin Proc Article Mayo Foundation for Medical Education and Research 2020-08 2020-06-06 /pmc/articles/PMC7275157/ /pubmed/32753131 http://dx.doi.org/10.1016/j.mayocp.2020.05.025 Text en © 2020 Mayo Foundation for Medical Education and Research. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Desai, Aakash Kulkarni, Amit Rajkumar, S. Vincent Gyawali, Bishal Clinical Trial End Points in Severe COVID-19 |
| title | Clinical Trial End Points in Severe COVID-19 |
| title_full | Clinical Trial End Points in Severe COVID-19 |
| title_fullStr | Clinical Trial End Points in Severe COVID-19 |
| title_full_unstemmed | Clinical Trial End Points in Severe COVID-19 |
| title_short | Clinical Trial End Points in Severe COVID-19 |
| title_sort | clinical trial end points in severe covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275157/ https://www.ncbi.nlm.nih.gov/pubmed/32753131 http://dx.doi.org/10.1016/j.mayocp.2020.05.025 |
| work_keys_str_mv | AT desaiaakash clinicaltrialendpointsinseverecovid19 AT kulkarniamit clinicaltrialendpointsinseverecovid19 AT rajkumarsvincent clinicaltrialendpointsinseverecovid19 AT gyawalibishal clinicaltrialendpointsinseverecovid19 |